Načítá se...
Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer
INTRODUCTION: Epidermal growth factor receptor (EGFR) targeted treatment has been evaluated but has not shown a clear clinical benefit for breast cancer. This review article aims to consider the knowledge of the biological background of EGFR pathways in dissecting clinical studies of EGFR targeted t...
Uloženo v:
| Vydáno v: | Expert Opin Investig Drugs |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826640/ https://ncbi.nlm.nih.gov/pubmed/28271910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2017.1299707 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|